Status:
COMPLETED
A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Transient Insomnia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess consumers' behaviors related to gabapentin self- selection and use, relative to warnings and directions for use, as described in the proposed over-the-counter (O...
Eligibility Criteria
Inclusion
- Age of 18 years or older with symptoms of sleeplessness
- Provided informed consent
Exclusion
- Contraindications to use of gabapentin
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
1254 Patients enrolled
Trial Details
Trial ID
NCT00659100
Start Date
August 1 2006
End Date
January 1 2007
Last Update
February 2 2021
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Anaheim, California, United States, 92801
2
Pfizer Investigational Site
Bonita, California, United States, 91902
3
Pfizer Investigational Site
Fallbrook, California, United States, 92028
4
Pfizer Investigational Site
Hacienda Heights, California, United States, 91746